Quick Answer
BioRestorative Therapies, Inc. reported Common Stock Shares Outstanding of 8.88 million shares for the year ending 2025.
- BioRestorative Therapies, Inc. showed an increase of +28.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: 627.99 million shares | Q2 2012: 673.08 million shares | Q3 2012: 689.83 million shares | Q1 2013: 16.41 million shares | Q2 2013: 16.74 million shares | Q3 2013: 17.11 million shares | Q1 2014: 21.83 million shares | Q2 2014: 25.02 million shares | Q3 2014: 31.02 million shares | Q1 2015: 37.19 million shares | Q2 2015: 2.79 million shares | Q3 2015: 2.85 million shares | Q1 2016: 3.93 million shares | Q2 2016: 4.14 million shares | Q3 2016: 4.44 million shares | Q1 2017: 5.33 million shares | Q2 2017: 5.49 million shares | Q3 2017: 5.61 million shares | Q1 2018: 6.48 million shares | Q2 2018: 6.75 million shares | Q3 2018: 8.72 million shares | Q1 2019: 14.73 million shares | Q2 2019: 19.79 million shares | Q3 2019: 23.72 million shares | Q1 2020: 1.59 billion shares | Q2 2020: 1.59 billion shares | Q3 2020: 1.59 billion shares | Q1 2021: 3.18 billion shares | Q2 2021: 3.35 billion shares | Q3 2021: 872,195 shares | Q1 2022: 3.63 million shares | Q2 2022: 3.64 million shares | Q3 2022: 3.65 million shares | Q1 2023: 3.77 million shares | Q2 2023: 3.98 million shares | Q3 2023: 4.67 million shares | Q1 2024: 6.77 million shares | Q2 2024: 6.92 million shares | Q3 2024: 6.92 million shares | Q1 2025: 7.50 million shares | Q2 2025: 7.98 million shares | Q3 2025: 7.98 million shares.
- Over the full 16 years of available data (2010 to 2025), BioRestorative Therapies, Inc.'s Common Stock Shares Outstanding has declined by 98.0%.
- Historical annual values: Fiscal year 2025: 8.88 million shares | Fiscal year 2024: 6.92 million shares | Fiscal year 2023: 4.71 million shares | Fiscal year 2022: 3.68 million shares | Fiscal year 2021: 3.52 million shares | Fiscal year 2020: 715,544 shares | Fiscal year 2019: 77.85 million shares | Fiscal year 2018: 11.73 million shares | Fiscal year 2017: 6.11 million shares | Fiscal year 2016: 4.70 million shares | Fiscal year 2015: 3.31 million shares | Fiscal year 2014: 1.70 million shares | Fiscal year 2013: 19.07 million shares | Fiscal year 2012: 14.88 million shares | Fiscal year 2011: 607.68 million shares | Fiscal year 2010: 433.22 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: